3631 results for «2267»
3631 results
TAVI new devices
22 May 2025 – From EuroPCR 2025
Explore the latest innovations in transcatheter aortic valve implantation (TAVI) devices with a focus on coronary protection strategies, cerebral embolic protection integration, management of ventricular migration, and overcoming anatomical challenges such as bicuspid and rheumatic valve disease using novel platforms.
Best companion's case on coronary complications
22 May 2025 – From EuroPCR 2025
This session showcases expert cases addressing coronary complications during PCI, including novel optimization approaches, managing intervention challenges under pressure, unconventional staged PCI strategies, and decision-making in high-risk scenarios to improve procedural safety and outcomes.
Best companions's case on complications in calcified lesions
22 May 2025 – From EuroPCR 2025
Delve into challenging cases involving complications in calcified coronary lesions managed with rotational atherectomy. Topics include unique uses of Rotablation, managing burr entrapment, complex calcium and tortuosity combinations, and addressing perforations resulting from stent optimization and burr retrieval in highly calcified vessels.
Peripheral expertise to the rescue
22 May 2025 – From EuroPCR 2025
This session addresses peripheral vascular expertise in managing access complications and occlusions. Learn about approaches to femoral access challenges during TAVI, endovascular solutions for iatrogenic hepatic artery rupture, and unconventional treatments for superficial femoral artery occlusions caused by covered stents.
Through decisions in complex left main PCI – Left main trifurcation
22 May 2025 – From EuroPCR 2025
This session offers an in-depth analysis of complex left main trifurcation PCI, covering evaluation through imaging and physiology, lesion preparation strategies, and treatment options including stepwise provisional approaches, upfront two-stent techniques, and drug-coated balloons.
Extensive anterior STEMI - Treatment strategies from SCAI A to E
22 May 2025 – From EuroPCR 2025
Explore comprehensive treatment strategies for extensive anterior STEMI, focusing on risk stratification across the SCAI shock stages A to E. Learn to adapt mechanical circulatory support appropriately and understand principles guiding device selection and utilization in hemodynamic instability.
Intracoronary imaging guidance for PCI
22 May 2025 – From EuroPCR 2025
This session highlights the value of intracoronary imaging guidance for PCI, showcasing optical coherence tomography in complex ACS lesions, long-term outcomes from imaging-guided PCI trials, AI-enhanced quantification, and comparative analyses of intravascular lithotripsy versus rotational atherectomy.
Assessment and management of patients with multivalvular disease involving the tricuspid valve
22 May 2025 – From EuroPCR 2025
Gain expertise on managing multivalvular disease involving the tricuspid valve by understanding diagnostic challenges, intervention indications, and associated pathophysiological factors. This session includes complex case studies focusing on combined valvular lesions and guideline limitations.
Role of coronary physiology in acute coronary syndrome patients
22 May 2025 – From EuroPCR 2025
Examine the role of coronary physiology in acute coronary syndrome patients, including plaque characteristics related to ACS risk, prognostic value of AngioIMR in STEMI, functional significance of lumen and plaque features, diagnostic accuracy of quantitative flow ratio, and the impact of adenosine administration routes on FFR...
Innovation to address unmet clinical needs in transcatheter valve therapies
22 May 2025 – From EuroPCR 2025
Discover innovations addressing unmet clinical needs in transcatheter valve therapies. This session shares case-based experiences including young aortic stenosis patients, mitral regurgitation with annular calcification, and severe tricuspid regurgitation with right ventricular dysfunction, alongside the latest advances in TAVI, TMVR, and tricuspid interventions.
What an interventional cardiologist should know about anti-thrombotics
22 May 2025 – From EuroPCR 2025
This session provides comprehensive knowledge on anti-thrombotic management for interventional cardiologists, emphasizing effective inhibition during acute STEMI, latest evidence implementation for high bleeding risk patients, and customization of dual antiplatelet therapy in patients with high thrombotic and low bleeding risks through clinical cases and evidence-based recommendations.
Procedural planning and risk stratification in multivessel PCI
22 May 2025 – From EuroPCR 2025
This session focuses on procedural planning and risk stratification in multivessel PCI, presenting data from the TALENT and FIRE trials, prognostic value of post-PCI physiological assessments, and an innovative study comparing large language models in managing complex interventional cardiology cases.
What did we learn from my TAVI complications?
22 May 2025 – From EuroPCR 2025
Review critical lessons from TAVI complications, focusing on early identification and management of access site issues and acute coronary obstruction. Learn effective preventive actions and procedural strategies to minimize severe TAVI-related complications through detailed case discussions.
Clinical and technical factors for decision-making in treatment of left main coronary artery disease
22 May 2025 – From EuroPCR 2025
Delve into decision-making factors in treating left main coronary artery disease, particularly in challenging scenarios. This session discusses the application of new SOLACI guidelines, critical strategy reflections, and real-world cases illustrating optimal left main PCI approaches.
A mindset shift in the cathlab: leveraging contemporary technologies for planning and guiding PCI in complex patients
22 May 2025 – From EuroPCR 2025
This session examines evolving catheterisation lab workflows, highlighting how integrated imaging, physiology, and procedural strategies are reshaping PCI practices. Speakers emphasize the importance of advanced pre-procedural planning using modalities such as intravascular ultrasound (IVUS) to optimise stent deployment, and cardiac computed tomography angiography (CCTA) to improve diagnosis...
A simple low profile solution to the pulmonary embolism problem: EKOS
21 May 2025 – From EuroPCR 2025
Discover a streamlined approach to pulmonary embolism treatment in this EuroPCR 2025 session. Learn how ultrasound-assisted thrombolysis improves right ventricular function and pulmonary perfusion while enabling timely reperfusion with low-dose thrombolytic therapy delivered directly to the clot. Explore the latest data from the HI-PEITHO randomised trial...
Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation
21 May 2025 – From EuroPCR 2025
Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....
Advanced imaging in structural heart disease interventions
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session brings together expert insights on the evolving role of 3D intracardiac echocardiography (ICE) in procedures like LAA closure, Mitral TEER, and Tricuspid TEER—highlighting how this advanced modality is reshaping procedural guidance.
You'll also discover how AI-enabled device detection technology is being integrated into...
Advancing renal denervation in China: from guidelines to practice
20 May 2025 – From EuroPCR 2025
Discover how renal denervation (RDN) is rapidly evolving in China to meet the needs of patients with uncontrolled hypertension. This EuroPCR 2025 session highlights recent guideline endorsements and approvals, patient selection based on drug resistance and cardiovascular risk, and the critical role of diagnostic screening. Gain...
Novelty in no-reflow management in STEMI patients
20 May 2025 – From EuroPCR 2025
Discover novel approaches to manage no-reflow phenomenon in STEMI patients. This session covers innovative therapies including the OPTI-STEMI trial strategies, mechanical thrombectomy, pharmacological interventions with Cangrelor, and super saturated oxygen therapy targeting coronary microcirculation preservation.
